Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership167,580 shares
Latest Disclosed Value $ 5,047,510
Squarepoint Ops LLC ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 167,580 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $5,047,510 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 140,866 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 18.96% during the quarter. The current value of the position is $5,501,651 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 531,800 of underlying shares valued at $16,017,816 USD and put options representing 502,300 of underlying shares valued at $15,129,276 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 167,580 26,714 18.96 5,048 14.81 0.0059
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 140,866 13,329 10.45 4,396 70.65 0.0047
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 127,537 38,477 43.20 2,576 72.65 0.0026
2025-08-27 2025-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 89,060 -576,737 -86.62 1,493 -85.42 0.0016
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 89,060 -576,737 1,493 0.0016
2025-08-27 2025-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 665,797 353,168 112.97 10,233 48.52 0.0124
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 665,797 353,168 10,233 0.0124
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 312,629 297,031 1,904.29 6,890 2,351.96 0.0068
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,598 15,598 281 0.0004
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -313,436 -100.00 0 -100.00
2023-08-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 313,436 287,547 1,110.69 2,360 930.57 0.0072
2023-05-15 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 25,889 25,889 229 0.0009
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -46,262 -100.00 0 -100.00
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 46,262 -48,025 -50.93 348 -60.68 0.0019
2022-05-16 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 94,287 -394 -0.42 885 16.75 0.0038
2022-02-14 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 94,681 -262,867 -73.52 758 -78.24 0.0020
2021-11-15 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 357,548 255,708 251.09 3,483 245.54 0.0100
2021-08-16 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 101,840 -558,269 -84.57 1,008 -86.77 0.0038
2021-05-17 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 660,109 554,855 527.16 7,618 649.80 0.0446
2021-02-16 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 105,254 105,254 1,016 0.0076
2020-11-16 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -122,418 -100.00 0 -100.00
2020-08-14 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 122,418 122,418 1,509 0.0244
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -80,508 -100.00 0 -100.00
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 80,508 -17,965 -18.24 789 16.54 0.0047
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 98,473 -97,508 -49.75 677 -62.58 0.0060
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 195,981 65,458 50.15 1,809 -11.63 0.0176
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 130,523 91,205 231.97 2,047 237.79 0.0217
2019-02-14 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 39,318 -34,398 -46.66 606 -61.84 0.0071
2018-11-14 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 73,716 50,713 220.46 1,588 184.08 0.0190
2018-08-14 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 23,003 23,003 559 0.0074
2018-02-14 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 0 -73,361 -100.00 0 -100.00
2017-11-14 2017-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 73,361 73,361 1,291 0.0248
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 531,800 -38.32 16,018 -40.48 n/a n/a n/a
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 862,200 120.68 26,909 240.97 n/a n/a n/a
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 390,700 5.00 7,892 26.56 n/a n/a n/a
2025-08-27 2025-06-30 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 372,100 -63.64 6,236 -60.35 n/a n/a n/a
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 372,100 6,236 n/a n/a n/a
2025-08-27 2025-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,023,400 155.40 15,730 78.11 n/a n/a n/a
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,023,400 15,730 n/a n/a n/a
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 400,700 100.35 8,831 145.03 n/a n/a n/a
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 200,000 3,604 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 502,300 -50.71 15,129 -52.43 n/a n/a n/a
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 1,019,000 26.62 31,803 95.63 n/a n/a n/a
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 804,800 73.75 16,257 109.40 n/a n/a n/a
2025-08-27 2025-06-30 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 463,200 -29.07 7,763 -22.65 n/a n/a n/a
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 463,200 7,763 n/a n/a n/a
2025-08-27 2025-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 653,000 13.15 10,037 -21.09 n/a n/a n/a
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 653,000 10,037 n/a n/a n/a
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 577,100 506.83 12,719 642.50 n/a n/a n/a
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 95,100 1,714 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.